πŸ‡ΊπŸ‡Έ FDA

Intelligence Β· Patent portfolio

Vera Therapeutics Patents

Full USPTO pharma patent portfolio for Vera Therapeutics β€” grant dates, expiration, and drug cross-links.

Patents
140
Expiring ≀24m
2

Quick answer

Vera Therapeutics has 140 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 2 expire within 24 months β€” use filters for patent-cliff planning.

Page 3 of 3

  1. US 9867873

    Factor IX polypeptides and methods of use thereof

    Expires Mon Jan 11 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 9856468

    Processable single chain molecules and polypeptides made using same

    Expires Mon Dec 28 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 9732311

    Alcoholic compositions having a lowered risk of acetaldehydemia

    Expires Mon Aug 10 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 9725496

    Immunoglobulin chimeric monomer-dimer hybrids

    Expires Mon Aug 03 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 9675676

    Factor IX polypeptides and methods of use thereof

    Expires Mon Jun 08 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 9670475

    Factor IX polypeptides and methods of use thereof

    Expires Mon Jun 01 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 9649320

    Non-hormonal steroid modulators of NF-ΞΊB for treatment of disease

    Expires Mon May 11 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 9636416

    Immunoglobulin chimeric monomer-dimer hybrids

    Expires Mon Apr 27 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 9637738

    Methods and agents to increase therapeutic dystrophin expression in muscle

    Expires Mon Apr 27 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 9629903

    Factor IX polypeptides and methods of use thereof

    Expires Mon Apr 20 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 9623088

    Factor VIII polypeptide formulations

    Expires Mon Apr 13 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 9623091

    Factor IX polypeptides and methods of use thereof

    Expires Mon Apr 13 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 9505719

    Synthesis and use of kinase inhibitors

    Expires Mon Nov 24 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 9447376

    Dried spore germinative compound mixtures

    Expires Mon Sep 15 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 9434758

    Non-hormonal steroid modulators of NF-ΞΊB for treatment of disease

    Expires Mon Sep 01 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 9375402

    Oral formulations of kinase inhibitors

    Expires Mon Jun 23 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 9290752

    Process for enhancing the amylase inhibitory efficacy from phaseolus vulgaris extracts

    Expires Mon Mar 17 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 9226937

    Compositions containing resveratrol and nucleotides

    Expires Mon Dec 31 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 9198921

    Non-hormonal steroid modulators of NF-ΞΊB for treatment of disease

    Expires Mon Nov 26 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 9138437

    Pyrimidine substituted purine compounds as kinase (S) inhibitors

    Expires Mon Sep 17 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 9114140

    Integrated neuromodulation system for mood enhancement of a living human subject

    Expires Mon Aug 20 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 9044423

    Alcoholic compositions having a lowered risk of acetaldehydemia

    Expires Mon May 28 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 8916528

    Compositions containing resveratrol and nucleotides

    Expires Mon Dec 18 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 8754080

    Pyrimidine substituted purine compounds as kinase (S) inhibitors

    Expires Mon Jun 12 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 8722884

    Pyrimidine derivatives for the treatment of abnormal cell growth

    Expires Mon May 08 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 8673887

    Non-hormonal steroid modulators of NF-kB for treatment of disease

    Expires Mon Mar 13 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 8658236

    Alcoholic compositions having a lowered risk of acetaldehydemia

    Expires Mon Feb 20 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 8609162

    Integrated neuromodulation system for mood enhancement of a living human subject

    Expires Mon Dec 12 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 8609838

    Pyrimidine substituted purine derivatives

    Expires Mon Dec 12 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 8404288

    Microbially-stable vitamin E solutions

    Expires Mon Mar 21 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. US 8247410

    Pyrimidine substituted purine derivatives

    Expires Mon Aug 16 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. US 7309702

    Arylpiperazines having activity at the serotonin 1A receptor

    Expires Mon Dec 13 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  33. US 7288263

    Compositions and methods for treatment of skin discoloration

    Expires Mon Oct 25 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  34. US 7033620

    Product and process for stabilizing Aloe vera gel

    Expires Mon Apr 20 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  35. US 7001908

    Arylpiperazines having activity at the serotonin 1A receptor

    Expires Mon Feb 16 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  36. US 6869624

    Product and process for stabilizing Aloe vera gel

    Expires Mon Mar 17 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  37. US 6713095

    Product and process for stabilizing aloe vera gel

    Expires Mon Mar 25 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  38. US 6395311

    Multicomponent biological vehicle

    Expires Mon May 23 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  39. US 6271214

    Process for the preparation of immunomodulatory polysaccharides from aloe

    Expires Mon Aug 02 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  40. US 6210680

    Method for the prevention and treatment of chronic venous insufficiency

    Expires Mon Mar 29 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  41. US 6133440

    Process for the preparation of immunomodulatory polysaccharides from aloe

    Expires Mon Oct 12 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  42. US 6123959

    Aqueous composition comprising active ingredients for the de-pigmentation of the skin

    Expires Mon Sep 21 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  43. US 6120785

    Antimycotic ectoparasiticidal product-external use

    Expires Mon Sep 14 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  44. US 6083976

    Method of synthesis of derivatives of aloesin

    Expires Mon Jun 29 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

Frequently asked questions

How many patents does Vera Therapeutics have?

140 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do Vera Therapeutics patents expire?

2 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.

Where does this data come from?

USPTO PatentsView bulk data filtered to pharmaceutical CPC classes (A61K, A61P), cross-linked to NovaPharmaNews company and drug profiles. See our data sources page for methodology.

Data attribution: Data sources Β· Patent directory

Drug approvals, clinical trials, M&A, event intelligence, and company updates β€” weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.